Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $8.0 billion point-of-care testing market. Chembio markets each of its DPP HIV 1/2 Assay, HIV 1/2 STAT-PAK Assay, and SURE CHECK HIV 1/2 Assay, with these Chembio brand names, in the U.S. and internationally both directly and through third-party distributors. The Company's…More SURE CHECK HIV 1/2 Assay previously has been exclusively sold in the U.S. as Clearview Complete HIV 1/2 Assay.
REPORT RATINGS
4.8 / 5.0 (226)
Chembio Diagnostics, Inc. reports have an aggregate usefulness score of 4.8 based on 226 reviews.